Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Overnight Post-Exercise Recovery After Protein Ingestion Prior to Sleep

This study has been completed.
Information provided by:
Maastricht University Medical Center Identifier:
First received: October 6, 2009
Last updated: April 19, 2011
Last verified: April 2011
The purpose of this study is to examine the effects of post-exercise protein ingestion prior to sleep on overnight protein kinetics and muscle recovery.

Condition Intervention
Resistance Training
Dietary Supplement: protein
Dietary Supplement: placebo

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Single Blind (Subject)
Primary Purpose: Basic Science
Official Title: Protein Ingestion Prior to Sleep as a Dietary Strategy to Improve Post-exercise, Overnight Recovery.

Resource links provided by NLM:

Further study details as provided by Maastricht University Medical Center:

Primary Outcome Measures:
  • muscle protein synthesis [ Time Frame: 10 hours ] [ Designated as safety issue: No ]

Estimated Enrollment: 24
Study Start Date: October 2009
Study Completion Date: December 2010
Primary Completion Date: August 2010 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: sweetened beverage Dietary Supplement: protein
Placebo Comparator: placebo control
Dietary Supplement: placebo
placebo control


Ages Eligible for Study:   20 Years to 30 Years   (Adult)
Genders Eligible for Study:   Male
Accepts Healthy Volunteers:   Yes

Inclusion Criteria:

  • Male
  • Age between 20 and 30 years
  • Healthy, recreationally active
  • BMI <25 kg/m2

Exclusion Criteria:

  • Use of medication
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT00991523

Maastricht MUMC
Maastricht, LI, Netherlands, 6202
Maastricht, Netherlands
Sponsors and Collaborators
Maastricht University Medical Center
Principal Investigator: Luc van Loon, PhD Maastricht University Medical Center
  More Information

Publications automatically indexed to this study by Identifier (NCT Number):
Responsible Party: Luc van Loon, University Hospital Maastricht Identifier: NCT00991523     History of Changes
Other Study ID Numbers: MEC 09-3-054 
Study First Received: October 6, 2009
Last Updated: April 19, 2011
Health Authority: Netherlands: The Central Committee on Research Involving Human Subjects (CCMO)

Keywords provided by Maastricht University Medical Center:
recovery processed this record on October 21, 2016